Edition:
United Kingdom

Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

7.19CAD
5:33pm BST
Change (% chg)

$-0.67 (-8.52%)
Prev Close
$7.86
Open
$7.90
Day's High
$7.91
Day's Low
$7.19
Volume
204,837
Avg. Vol
188,708
52-wk High
$14.75
52-wk Low
$4.96

Chart for

About

Theratechnologies Inc is a Canada-based specialty pharmaceutical company. The Company addresses medical needs to promote healthy living for human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of... (more)

Overall

Beta: 1.84
Market Cap(Mil.): $588.89
Shares Outstanding(Mil.): 74.92
Dividend: --
Yield (%): --

Financials

  TH.TO Industry Sector
P/E (TTM): -- 30.92 33.69
EPS (TTM): -0.19 -- --
ROI: -32.89 14.76 14.30
ROE: -39.35 16.26 16.03

BRIEF-FDA Releases Theratechnologies From Post-Approval Commitments Related To EGRIFTA

* FDA RELEASES THERATECHNOLOGIES FROM POST-APPROVAL COMMITMENTS RELATED TO EGRIFTA® (TESAMORELIN FOR INJECTION)

01 May 2018

BRIEF-Theratechnologies To Seek Regulatory Approval Of Trogarzo In Europe

* THERATECHNOLOGIES TO SEEK REGULATORY APPROVAL OF TROGARZO™ (IBALIZUMAB) IN EUROPE

24 Apr 2018

Earnings vs. Estimates